Cargando…
Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms
The purpose of this investigation was to explore the prognostic value of phospholipase C delta (PLCD) genes in early stage pancreatic ductal adenocarcinoma (PDAC) and its potential molecular mechanisms. The prognostic value of PLCD genes in early stage PDAC was assessed using the Kaplan‐Meier method...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997088/ https://www.ncbi.nlm.nih.gov/pubmed/31808619 http://dx.doi.org/10.1002/cam4.2699 |
_version_ | 1783493619723796480 |
---|---|
author | Zhou, Xin Liao, Xiwen Wang, Xiangkun Huang, Ketuan Yang, Chengkun Yu, Tingdong Han, Chuangye Zhu, Guangzhi Su, Hao Han, Quanfa Chen, Zijun Huang, Jianlv Gong, Yizhen Ruan, Guotian Ye, Xinping Peng, Tao |
author_facet | Zhou, Xin Liao, Xiwen Wang, Xiangkun Huang, Ketuan Yang, Chengkun Yu, Tingdong Han, Chuangye Zhu, Guangzhi Su, Hao Han, Quanfa Chen, Zijun Huang, Jianlv Gong, Yizhen Ruan, Guotian Ye, Xinping Peng, Tao |
author_sort | Zhou, Xin |
collection | PubMed |
description | The purpose of this investigation was to explore the prognostic value of phospholipase C delta (PLCD) genes in early stage pancreatic ductal adenocarcinoma (PDAC) and its potential molecular mechanisms. The prognostic value of PLCD genes in early stage PDAC was assessed using the Kaplan‐Meier method and multivariate Cox proportional hazards regression model. Genome‐wide correlation analysis was performed on PLCD3 to identify the highly correlated genes in the transcriptome. Then, PLCD3 and these correlated genes together underwent a bioinformatics analysis to elucidate the potential molecular biological functions of PLCD3 in PDAC. PLCD1 and PLCD3 are significantly overexpressed in PDAC. In PDAC patients, PLCD3 is overexpressed in certain groups of people with a history of alcoholism (P = .032). High expression of PLCD3 was found to be associated with lower overall survival (OS) of patients with early stage PDAC (P = .020; adjusted P = .016). A combination of PLCD3 and clinical variables was able to better predict the outcome of patients with early stage PDAC. These clinical variables are histological grade (P = .001; adjusted P = .001), targeted molecular therapy (P < .001; adjusted P < .001), radiation therapy (P = .002; adjusted P = .039), and residual resection (P = .001; adjusted P = .002). The bioinformatics analysis revealed that PLCD3 is associated with angiogenesis, intracellular signal transduction, and regulation of cell proliferation. In conclusion, PLCD3 may be a potential prognostic biomarker for early stage PDAC. |
format | Online Article Text |
id | pubmed-6997088 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-69970882020-02-05 Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms Zhou, Xin Liao, Xiwen Wang, Xiangkun Huang, Ketuan Yang, Chengkun Yu, Tingdong Han, Chuangye Zhu, Guangzhi Su, Hao Han, Quanfa Chen, Zijun Huang, Jianlv Gong, Yizhen Ruan, Guotian Ye, Xinping Peng, Tao Cancer Med Clinical Cancer Research The purpose of this investigation was to explore the prognostic value of phospholipase C delta (PLCD) genes in early stage pancreatic ductal adenocarcinoma (PDAC) and its potential molecular mechanisms. The prognostic value of PLCD genes in early stage PDAC was assessed using the Kaplan‐Meier method and multivariate Cox proportional hazards regression model. Genome‐wide correlation analysis was performed on PLCD3 to identify the highly correlated genes in the transcriptome. Then, PLCD3 and these correlated genes together underwent a bioinformatics analysis to elucidate the potential molecular biological functions of PLCD3 in PDAC. PLCD1 and PLCD3 are significantly overexpressed in PDAC. In PDAC patients, PLCD3 is overexpressed in certain groups of people with a history of alcoholism (P = .032). High expression of PLCD3 was found to be associated with lower overall survival (OS) of patients with early stage PDAC (P = .020; adjusted P = .016). A combination of PLCD3 and clinical variables was able to better predict the outcome of patients with early stage PDAC. These clinical variables are histological grade (P = .001; adjusted P = .001), targeted molecular therapy (P < .001; adjusted P < .001), radiation therapy (P = .002; adjusted P = .039), and residual resection (P = .001; adjusted P = .002). The bioinformatics analysis revealed that PLCD3 is associated with angiogenesis, intracellular signal transduction, and regulation of cell proliferation. In conclusion, PLCD3 may be a potential prognostic biomarker for early stage PDAC. John Wiley and Sons Inc. 2019-12-06 /pmc/articles/PMC6997088/ /pubmed/31808619 http://dx.doi.org/10.1002/cam4.2699 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Zhou, Xin Liao, Xiwen Wang, Xiangkun Huang, Ketuan Yang, Chengkun Yu, Tingdong Han, Chuangye Zhu, Guangzhi Su, Hao Han, Quanfa Chen, Zijun Huang, Jianlv Gong, Yizhen Ruan, Guotian Ye, Xinping Peng, Tao Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms |
title | Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms |
title_full | Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms |
title_fullStr | Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms |
title_full_unstemmed | Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms |
title_short | Noteworthy prognostic value of phospholipase C delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms |
title_sort | noteworthy prognostic value of phospholipase c delta genes in early stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy and potential molecular mechanisms |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997088/ https://www.ncbi.nlm.nih.gov/pubmed/31808619 http://dx.doi.org/10.1002/cam4.2699 |
work_keys_str_mv | AT zhouxin noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT liaoxiwen noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT wangxiangkun noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT huangketuan noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT yangchengkun noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT yutingdong noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT hanchuangye noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT zhuguangzhi noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT suhao noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT hanquanfa noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT chenzijun noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT huangjianlv noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT gongyizhen noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT ruanguotian noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT yexinping noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms AT pengtao noteworthyprognosticvalueofphospholipasecdeltagenesinearlystagepancreaticductaladenocarcinomapatientsafterpancreaticoduodenectomyandpotentialmolecularmechanisms |